Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2012
12/13/2012WO2012169893A1 Transcription factor modulating terpene biosynthesis
12/13/2012WO2012169798A2 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
12/13/2012WO2012169699A1 Novel insecticidal protein, composition for controlling pests and method for controlling pests using same
12/13/2012WO2012169435A1 Freeze-dried preparation containing high-purity pth and method for producing same
12/13/2012WO2012169200A1 Sema5b peptides and vaccines including the same
12/13/2012WO2012168763A1 Gm bzip110 transcriptional gene and use thereof for enhancing plant tolerance to salt and/or drought
12/13/2012WO2012168680A1 Pharmaceutical preparation comprising recombinant fsh
12/13/2012WO2012168532A1 Thermosensitive, bioactive biopolymer and associated method of cell harvesting
12/13/2012WO2012168522A1 Method for identifying carbonylated histones
12/13/2012WO2012168519A1 Mixture of multifunctional peptides or polypeptides or combinations thereof that are capable of forming a 2d or 3d matrix for care of the skin, mucosae, scalp and/or hair, and the use thereof in cosmetic or dermopharmaceutical compositions
12/13/2012WO2012168487A1 Peptide carrier fusion proteins as allergy vaccines
12/13/2012WO2012168480A1 Agents and methods for producing hiv-capsid derived non-infectious adjuvants
12/13/2012WO2012168459A1 Methods for identifying adult stem cells
12/13/2012WO2012168432A1 Polypeptides
12/13/2012WO2012168431A2 Polypeptides
12/13/2012WO2012168430A2 Polypeptides
12/13/2012WO2012168399A1 Methods for predicting, treating and modelling hormone resistance
12/13/2012WO2012168304A1 Protein having nuclease activity, fusion proteins and uses thereof
12/13/2012WO2012168257A1 A method for enhancing the fermentative potential and growth rate of microorganisms under anaerobiosis
12/13/2012WO2012168196A1 Production and use of a peptide having an n-terminal 11c-marked acetyl
12/13/2012WO2012167744A1 Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
12/13/2012WO2012167617A1 β INHIBITING PROTEIN 1, FRAGMENTS THEREOF, AND USE THEREOF
12/13/2012WO2012167382A1 Compositions and methods for glioblastoma treatment
12/13/2012WO2012167370A1 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
12/13/2012WO2012167346A1 Anti-ricin antibodies and uses thereof
12/13/2012WO2012135637A3 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis
12/13/2012WO2012131680A9 Compositions and methods for treating inflammation
12/13/2012WO2012126118A8 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
12/13/2012WO2012118323A3 Fusion protein comprising albumin and a retinol-binding protein
12/13/2012WO2012101509A3 Immunological compositions comprising hiv gp41 polypeptide derivatives
12/13/2012WO2004070015A9 Nematode pan and zp receptor-like sequences
12/13/2012US20120317678 Gene Dro1 Controlling Deep-Rooted Characteristics of Plant and Utilization of Same
12/13/2012US20120317676 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom
12/13/2012US20120317675 Ultra-low trypsin inhibitor soybean
12/13/2012US20120316646 Collagen coated article
12/13/2012US20120316322 Design and use of new recombinant interferons with altered spatial configuration and three-dimensional structure
12/13/2012US20120316321 Methods for identifying markers for early-stage human cancer, cancer progression and recurrence
12/13/2012US20120316320 Process of managed ecosystem fermentation
12/13/2012US20120316319 Arylethynylxanthene dyes
12/13/2012US20120316119 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity
12/13/2012US20120316114 Variants of C-type Natriuretic Peptide
12/13/2012US20120316113 Fgf based fibrin binding peptides
12/13/2012US20120316109 Polymer-conjugated glycosylated neublastin
12/13/2012US20120316107 Fibrillation-resistant insulin and insulin analogues
12/13/2012US20120316104 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
12/13/2012US20120316102 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
12/13/2012US20120315703 Cells and methods for obtaining them
12/13/2012US20120315698 Methods for sterilizing materials containing biologically active agents
12/13/2012US20120315686 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
12/13/2012US20120315685 Coated Substrates and Methods of Preparing the Same
12/13/2012US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
12/13/2012US20120315631 Tumor suppressor designated ts10q23.3
12/13/2012US20120315321 Immunological methods and compositions for the treatment of alzheimer's disease
12/13/2012US20120315293 Antigen Delivery Vectors and Constructs
12/13/2012US20120315292 Immunogenic compositions for streptococcus pyogenes
12/13/2012US20120315270 Rsv immunogens, antibodies and compositions thereof
12/13/2012US20120315256 Use of transforming growth factor - beta 1 (tgf-b1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
12/13/2012US20120315245 Immunomodulator polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections
12/13/2012DE102005027557B4 Koexpression von Chaperonen der Hsp70-Familie zur Verstärkung der Expressionen von G-Protein gekoppelten Rezeptoren Co-expression of chaperones of the Hsp70 family for enhancing the expression of G-protein coupled receptors
12/13/2012CA2838884A1 Polypeptides
12/13/2012CA2838833A1 Pro-coagulant compounds and methods of use thereof
12/13/2012CA2838503A1 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
12/13/2012CA2838262A1 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
12/13/2012CA2838217A1 Peptide carrier fusion proteins as allergy vaccines
12/13/2012CA2838186A1 Scaffold-kinase interaction blockades and uses thereof in treating cancer
12/13/2012CA2838013A1 Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes
12/13/2012CA2837995A1 Method of producing factor viii proteins by recombinant methods
12/13/2012CA2837473A1 Human antigen binding proteins that bind to a complex comprising .beta.-klotho and an fgf receptor
12/13/2012CA2837357A1 Anti-ricin antibodies and uses thereof
12/13/2012CA2836921A1 Hepatocyte based insulin gene therapy for diabetes
12/12/2012EP2533045A1 Methods for identifying adult stem cells
12/12/2012EP2532733A1 A method for enhancing the fermentative poteltial and growth rate of microorganisms under anaerobiosis
12/12/2012EP2532675A1 Long-acting polypeptides and methods of producing and administering same
12/12/2012EP2532674A1 Long-acting polypeptides and methods of producing and administering same
12/12/2012EP2532672A2 Chromatography matrices including novel Staphylococcus aureus protein A based ligands
12/12/2012EP2532358A1 Therapeutic Agent for Infections
12/12/2012EP2532357A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/12/2012EP2532356A1 Implantable power sources and sensors
12/12/2012EP2531619A2 Hypoxia-related gene signatures for cancer classification
12/12/2012EP2531599A2 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
12/12/2012EP2531590A2 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains
12/12/2012EP2531524A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/12/2012EP2531523A1 Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
12/12/2012EP2531522A1 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
12/12/2012EP2531521A1 Use of proteases for gluten intolerance
12/12/2012EP2531518A1 Oligopeptidic compounds and uses thereof
12/12/2012EP2531213A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
12/12/2012EP2531212A1 Bunyavirus vaccine
12/12/2012EP2531210A1 Vaccine and methods of use against strongyloides stercoralis infection
12/12/2012EP2531206A1 Chlorotoxin polypeptides and conjugates and uses thereof
12/12/2012EP2531204A1 Template - fixed peptidomimetics with cxcr7 modulating activity
12/12/2012CN1956998B Method for the purification of albumin conjugates
12/12/2012CN1890567B Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/12/2012CN1810832B Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
12/12/2012CN1484650B Urocortin proteins and uses thereof
12/12/2012CN102822199A Medicinal composition for treating and/or preventing cancer
12/12/2012CN102822198A CTLA4 proteins and their uses
12/12/2012CN102822197A BMP-7 variants with reduced immunogenicity
12/12/2012CN102822196A Methods of intracellular conversion of single-chain proteins into their di-chain form
12/12/2012CN102822195A Thermophilic mannanohydrolase and fracturing fluids containing the same
1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 2916